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Introduction
• Atrial Fibrillation (AF) is a cardiac arrhythmia
– Caused by chaotic electrical signals
– Mortality risk: reduced cardiac output & thrombus 
• Pulmonary Vein Isolation (PVI) is an established and effective 
therapy for AF 
– Catheter ablation of Pulmonary veins
• High Power Short Duration (HPSD) ablation 
method is novel in PVI compared to 
Standard Power Standard Duration (SPSD)
and Temperature Controlled Non-Contact 
(TCNC)
– HPSD has been shown to reduce 
ablation time without negative impacts 




– What are the clinical and procedural outcomes of using
HPSD compared to SPSD and TCNC ablation methods 
for PVI?
• Hypothesis
– HPSD ablation for PVI would take less time, require less 
ablation, have fewer compilations and have better clinical 
outcomes (less AF recurrence, fewer repeat ablations) 
than PVI with SPSD and TCNC ablation methods
Approach & Results
• Study design 
– Retrospective Chart Review
• Population
– 171 patients with AF that underwent PVI at Jefferson
• From July 2013 to November 2019 
• 76 HPSD, 51 SPSD, 44 TCNC  
• Rationale for Approach
– Compare clinical and procedural outcomes of ablation 
techniques as ablation methods are evolving
– Variables include ablation time, safety outcomes, 
procedural outcomes, and follow up data (3 and 12 month)
Approach & Results
• Findings
– HPSD reduced total ablation time 
• Reduced Left and Right Pulmonary vein 
isolation time
• Reduced Radiofrequency ablation time
– There was no difference in ability to 
reinduce arrhythmias between groups
Approach & Results
• Findings
– 3 month and 12 month outcomes
• No difference in overall sinus rhythm, Type of AF, Left Atrial Volume, 
CHA2DSVASc, or Left Ventricular Ejection Fraction 
Conclusions
• HPSD ablation in PVI notably reduced ablation 
procedure time with similar sinus maintenance and 
safety profile compared to SPSD and TCNC
– Our research supports the use of HPSD ablation 
– Agree with current literature and acceptance of 
using HPSD ablation methods 
Future Directions
• Future studies could examine long term outcomes 
at 5 years and 10 years with larger a cohort 
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